Azd6234
Obesity Or Overweight, Weight-Related Comorbidity, With/Without Diabetes Mellitus, Type 2
Phase III
Recruiting
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
Aug 10, 2026
Lenalidomide, Cyclophosphamide, Azd0120, Fludarabine, Melphalan
Newly Diagnosed Multiple Myeloma (Ndmm)
Phase III
Not Yet Recruiting
A Phase III, Multicentre Study to Evaluate Consolidation Treatment With AZD0120 Compared With ASCT, in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible (DURGA-6).
Jul 22, 2026
Elecoglipron Reference Formulation Dose A, Elecoglipron Test Formulation 1 Dose A, Elecoglipron Reference Formulation Dose B, Elecoglipron Test Formulation 1 Dose B, Elecoglipron Test Formulation 2 Dose A, Elecoglipron Test Formulation 2 Dose B
Healthy Participants
Phase I
Recruiting
A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
Jul 20, 2026
Saruparib, Enzalutamide, Darolutamide, Abiraterone
Metastatic Hormone-Sensitive Prostate Cancer (Mhspc)
Phase III
Not Yet Recruiting
Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)
Jul 14, 2026
Azd6489, Licensed Rsv Vaccine #1, Licensed Rsv Vaccine #2
Rsv Respiratory Syncytial Virus
Phase I/II
Active Not Recruiting
A Study to Characterize the Safety and Immunogenicity of AZD6489 in Participants 60 Years of Age and Older (ARIES)
Jul 07, 2026
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does AstraZeneca PLC (AZN1N) have in its pipeline
AZN1N is currently developing the following drugs: Azd0543, Elecoglipron, Azd6234. These drug candidates are in various stages of clinical development as the company works toward FDA approval.